Literature DB >> 25895034

Small steps for idiopathic giant cell myocarditis.

Jeffrey A Shih1, Jennifer A Shih.   

Abstract

Idiopathic giant cell myocarditis (IGCM) is a rare disease causing progressive myocarditis characterized by myocardial necrosis and giant cells. Patients often present with rapidly progressive heart failure, ventricular arrhythmias, and heart block. Without treatment, the disease often results in progressive pump failure requiring urgent cardiac transplantation or the need for mechanical circulatory support. The underlying pathophysiologic mechanisms are not yet defined but appear to involve genetics, autoimmune disorders, and possibly environmental factors such as viruses. Combined immunosuppressive regimens appear to prolong survival from death or cardiac transplant. Nevertheless, cardiac transplant is an effective treatment. The disease can recur in the transplanted heart resulting in death or the need for retransplant.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895034     DOI: 10.1007/s11897-015-0260-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  48 in total

1.  ISOLATED MYOCARDITIS.

Authors:  R WHITEHEAD
Journal:  Br Heart J       Date:  1965-03

2.  Histologic and cytokine response to immunosuppression in giant-cell myocarditis.

Authors:  N T Levy; L J Olson; C Weyand; A Brack; H D Tazelaar; W D Edwards; S C Hammill
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

3.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

4.  Response of recurrent giant cell myocarditis in a transplanted heart to intensive immunosuppression.

Authors:  G Kong; B Madden; N Spyrou; A Pomerance; A Mitchell; M Yacoub
Journal:  Eur Heart J       Date:  1991-04       Impact factor: 29.983

5.  Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.

Authors:  Riina Kandolin; Jukka Lehtonen; Kaisa Salmenkivi; Anne Räisänen-Sokolowski; Jyri Lommi; Markku Kupari
Journal:  Circ Heart Fail       Date:  2012-11-13       Impact factor: 8.790

6.  Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Harikrishna Tandri; Elizabeth R Duffy; Jeffrey R Winterfield; Shannon Mackey-Bojack; Maria M Picken; Leslie T Cooper; David J Wilber; Frank I Marcus; Cristina Basso; Gaetano Thiene; Adalena Tsatsopoulou; Nikos Protonotarios; William G Stevenson; William J McKenna; Shiva Gautam; Daniel G Remick; Hugh Calkins; Jeffrey E Saffitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-22

7.  Mechanical assist and transplantation for treatment of giant cell myocarditis.

Authors:  Joerg Seeburger; Nicolas Doll; Susanne Doll; Michael Andrew Borger; Friedrich Wilhelm Mohr
Journal:  Can J Cardiol       Date:  2010-02       Impact factor: 5.223

8.  Gene expression in giant cell myocarditis: Altered expression of immune response genes.

Authors:  Michelle M Kittleson; Khalid M Minhas; Rafael A Irizarry; Shui Q Ye; Gina Edness; Elayne Breton; John V Conte; Gordon Tomaselli; Joe G N Garcia; Joshua M Hare
Journal:  Int J Cardiol       Date:  2005-07-10       Impact factor: 4.164

9.  A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis.

Authors:  Yuji Okura; G William Dec; Joshua M Hare; Makoto Kodama; Gerald J Berry; Henry D Tazelaar; Kent R Bailey; Leslie T Cooper
Journal:  J Am Coll Cardiol       Date:  2003-01-15       Impact factor: 24.094

10.  Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies.

Authors:  Adita Mascaro-Blanco; Kathy Alvarez; Xichun Yu; JoAnn Lindenfeld; Leann Olansky; Timothy Lyons; David Duvall; Janet S Heuser; Albina Gosmanova; Carl J Rubenstein; Leslie T Cooper; David C Kem; Madeleine W Cunningham
Journal:  Autoimmunity       Date:  2008-09       Impact factor: 2.815

View more
  4 in total

1.  Giant Cell Myocarditis Presenting with Predominant Right Ventricular Dysfunction Treated Successfully with Heart Transplantation.

Authors:  Chih-Hsien Lin; Po-Sheng Chen; Chih-Chan Lin; Zhih-Cherng Chen; Wei-Ting Chang
Journal:  Acta Cardiol Sin       Date:  2021-01       Impact factor: 2.672

2.  Importance of endomyocardial biopsy in distinguishing between cardiac sarcoidosis and giant cell myocarditis : Need to distinguish between sarcoidosis and giant cell myocarditis.

Authors:  Petr Kuchynka; Tomas Palecek; Lukas Lambert; Antonin Fikrle; Ivana Vitkova; Martin Masek; Sudheera Magage; Ales Linhart
Journal:  Wien Klin Wochenschr       Date:  2018-11-23       Impact factor: 1.704

3.  Giant cell myocarditis: a life-threatening disorder heralded by orbital myositis.

Authors:  Muhammad Sajawal Ali; Benjamin I Mba; Aliya Noor Husain; Farah Diba Ciftci
Journal:  BMJ Case Rep       Date:  2016-03-23

4.  Giant cell myositis and myocarditis revisited.

Authors:  Piraye Oflazer
Journal:  Acta Myol       Date:  2020-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.